Skip to content

Robot-assisted laparoscopic radical prostatectomy versus laparoscopic radical prostatectomy: A comparison of one surgeon's outcomes

Effectiveness and Safety of robot-assisted laparosopic radical prostatectomy versus laparoscopic radical prostatectomy in patients with prostate cancer by one experienced laparoscopic surgeon :A prospective controlled Trial from China

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12612001219875
Enrollment
50
Registered
2012-11-19
Start date
2012-03-20
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

We assessed the learning curve for an experienced laparoscopic surgeon during the transition for laparoscopic surgery to the robot-assisted operations.So we conducted the RCT and compared the perioperative outcomes of the 2 groups.One group were 25 cases of laparoscopicradical prostatectomy and another were 25 cases of robot-assisted laparoscopic prostate cancer

Interventions

25 male patients with clinically localized prostatic carcinoma underwent prostatectomy by robot-assisted approach by a single surgeon(using the da Vinci Surgical System). The estimated operative time is around 3-4hours.The surgical technique are transperitoneally,antegrade, energy-free (use of surgical suture needle to control the prostatic vascular structure with no use of thermocoagulation, either mono or bipolar at the lateral aspect of the prostate) Participants will be monitored for 1 year

25 male patients with clinically localized prostatic carcinoma underwent prostatectomy by robot-assisted approach by a single surgeon(using the da Vinci Surgical System). The estimated operative time is around 3-4hours.The surgical technique are transperitoneally,antegrade, energy-free (use of surgical suture needle to control the prostatic vascular structure with no use of thermocoagulation, either mono or bipolar at the lateral aspect of the prostate) Participants will be monitored for 1 year post surgery

Sponsors

Changhai Hospital
Lead SponsorHospital

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
Male
Age
40 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

(1) Prostate cancer patients diagnosed by pathologic examination , The life expectancy of more than 10 years, localized prostate cancer(T1a-T2c) (2) written informed consent was obtained.

Exclusion criteria

(1)Lymphatic metastasis and bone metastasis assessed by computed tomography, magnetic resonance imaging,Positron Emission Computed Tomography ; (2) patients had received neoadjuvant chemotherapy;(3) complicated by cardiopulmonary dysfunction,celiac inflammation,coagulation abnormalities

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026